Bone Disease

'Vertebroplasty better than conservative treatment': Vertos II trial

12/08/2010 | Adding to the controversy over the efficacy of vertebroplasty, an open-label trial published today concludes that the treatment is safe and effective in a subgroup of patients with osteoporotic vertebral compression fractures.


Inaccurate media reports undermine osteoporosis treatment

04/08/2010 | Inaccurate reporting of links between bisphosphonate use and the risk of osteonecrosis of the jaw potentially led to 70 hip fractures, 60 other fractures and 14 deaths, according to experts writing in the Medical Journal of Australia.


Myocardial infarction risk prompts calcium rethink

04/08/2010 | Think dietary changes before supplements when assessing a patient’s calcium intake, experts say, after an analysis found supplementation was associated with an increased risk of MI.


Oral drugs cause osteonecrosis of the jaw

08/07/2010 | Osteonecrosis of the jaw is not just a problem for IV bisphosphonates used in cancer patients but is also emerging as a significant side effect in osteoporosis patients taking oral drugs, surgeons say this month.


Genetic factors affect risk of vitamin D insufficiency

17/06/2010 | Three genetic variants have been linked by UK researchers with a two-fold increased risk of vitamin D insufficiency.


CAM use high and underreported in osteoporosis patients

03/06/2010 | Physicians should routinely ask osteoporosis patients whether they take complementary and alternative medicines, due to their high rates of use and possible clinical interactions, researchers say.


Treatment gap between evidence and practice: STOP fracture

26/05/2010 | All women over 65 years of age who are hospitalised should be screened for vertebral fractures, even those presenting with non-osteoporosis related medical conditions, researchers say.


Focus on cortical bone loss in osteoporosis

19/05/2010 | Accurate assessment of changes in bone structure, and especially of cortical bone loss, would improve the identification of patients at high risk of fracture and help target effective treatment, Australian researchers have claimed.


Atypical femoral fractures not increased by bisphosphonates

19/05/2010 | Concerns that bisphosphonate treatment increases the risk of atypical femoral shaft fractures have been allayed by a study showing no adverse effect among 14,000 women enrolled in three randomised controlled trials.


Women unaware of fracture risk

15/04/2010 | Many women at increased risk of fracture fail to appreciate their risk, research shows.


More Bone Disease news

Recent comments

Most viewed articles this week

Related sites